Our Human Emulation System sets a new standard for recreating true-to-life human biology and is being used to advance product innovation, design, and safety across a range of applications, including drug development, agriculture, cosmetics, food, and chemical-based consumer products. We are continuously developing a wide range of Organ-Chips and disease models through collaborations with industry partners and internal R&D programs, and are also working with clinical partners to produce Organ-Chips personalized with individual patients? stem cells, for applications in precision medicine and personalized health. Our founding team pioneered Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. We hold the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for Organs-on-Chips technology and related systems Mission:?Mission: Based on our Organs-on-Chips technology, we're creating a new living system that emulates human biology ? for understanding how different diseases, medicines, chemicals, and foods affect human health. Our team?s work is driven by the following three guiding principles: ? To create a new framework for understanding human biology ? To use our system and data to improve human health ? To enable a new era of personal health applications
51 to 200 Employees
TypeCompany - Private
Revenue$1 to $5 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2014